Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

5.64
+0.46008.88%
Post-market: 5.52-0.1200-2.13%19:48 EDT
Volume:1.36M
Turnover:7.55M
Market Cap:289.18M
PE:-1.67
High:5.67
Open:5.20
Low:5.20
Close:5.18
52wk High:14.06
52wk Low:4.36
Shares:51.27M
Float Shares:48.37M
Volume Ratio:1.11
T/O Rate:2.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3870
EPS(LYR):0.9300
ROE:-40.29%
ROA:6.93%
PB:0.85
PE(LYR):6.06

Loading ...

Emergent BioSolutions Inc - Closes New $150 Mln Term Loan With Orbimed

THOMSON REUTERS
·
Apr 17

Press Release: Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility

Dow Jones
·
Apr 17

Emergent BioSolutions wins British Columbia order to supply Narcan nasal spray for THN program

Reuters
·
Apr 10

Emergent BioSolutions Partners With British Columbia to Supply Narcan® Nasal Spray for the Launch of the Expanded Bc Take Home Naloxone Program

THOMSON REUTERS
·
Apr 10

Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

GlobeNewswire
·
Apr 07

Emergent BioSolutions SVP Paul Anthony Williams disposes of $0m common shares

Reuters
·
Apr 04

Emergent BioSolutions to attend international preparedness, health security conferences

Reuters
·
Apr 02

Emergent BioSolutions announces over $60M in government contract awards

TIPRANKS
·
Mar 26

Emergent BioSolutions wins $54 million ASPR VIGIV contract option; secures $6.6 million ACAM2000 orders from international government partner

Reuters
·
Mar 26

Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures

GlobeNewswire
·
Mar 26

Emergent BioSolutions Inc. Announces Annual Meeting of Stockholders

Reuters
·
Mar 21

Mpox Is on the Rise in the U.S. 3 Vaccine Stocks Worth a Second Look. -- Barrons.com

Dow Jones
·
Mar 18

Emergent Biosolutions Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 09

U.S. RESEARCH ROUNDUP-Dow, Oracle, Shopify

Reuters
·
Mar 09

Emergent BioSolutions Inc. Files Initial Beneficial Ownership Statement for Director John D. Fowler Jr

Reuters
·
Mar 06

Press Release: Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

Dow Jones
·
Mar 03

Nyse Order Imbalance 75175.0 Shares on Buy Side

THOMSON REUTERS
·
Mar 03

Emergent BioSolutions Down Over 25%, on Pace for Largest Percent Decrease Since August 2024 -- Data Talk

Dow Jones
·
Feb 28

Emergent Biosolutions Slide After Widening 4Q Loss, Logging Lower Revenue

Dow Jones
·
Feb 27

Emergent BioSolutions Shares Down 20% Premarket After Q4 Revenue Falls

THOMSON REUTERS
·
Feb 27